Global Vaccines Market is expected to reach US$ 108.82 billion by 2032 | Top key players - GSK plc., Merck & Co., Inc., Pfizer Inc.

Market Size and Growth:

The Global Vaccines Market reached US$ 77.01 billion in 2024 and is expected to reach US$ 108.82 billion by 2032, growing at a CAGR of 3.9% during the forecast period 2025-2032.

Vaccines Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/vaccines-market?sz

The Vaccines Market refers to the global industry focused on the research, development, production, and distribution of vaccines that prevent infectious diseases and boost immunity. It includes various vaccine types, such as preventive, therapeutic, pediatric, and adult vaccines, with demand driven by rising disease prevalence, immunization programs, technological advancements, and growing public health awareness.

Industry News of USA and Japan:

USA

August 27, 2025: Pfizer and BioNTech received FDA approval for their updated COVID-19 vaccine, COMIRNATY, for specific at-risk populations.

September 3, 2025: Florida's state government announced plans to end all vaccine mandates, including those for school entry.

Japan

May 5, 2025: Novavax and Takeda updated their collaboration to enhance the availability of Novavax's non-mRNA COVID-19 vaccine in Japan.

May 28, 2025: A health ministry panel in Japan agreed to use descendent lineages of the JN.1 strain for the 2025-2026 season's COVID-19 vaccines.

Key Players:

Pfizer Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Dr. Reddy's Laboratories Ltd.
Intas Pharmaceuticals
Akron Biotech
Sandoz Group AG
ratiopharm GmbH
Biocon Limited.

Growth Forecast Projected:

The Global Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=vaccines-market

Market Segmentation:

By Type: Conjugate Vaccines, Inactivated Vaccines, Live-attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Others.

By Drug Type: Monovalent Vaccines, Bivalent Vaccines, Multivalent Vaccines.

By Disease Indication: Chickenpox, Cholera, Diphtheria, Influenza, Hepatitis, Measles, Mumps, Polio, Rabies, Others.

By Route of Administration: Intramuscular, Subcutaneous, Intranasal, Others.

By End User: Community Hospitals, Hospitals, Specialty Centers, Clinics, Others.

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/vaccines-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Vaccines market?

➠ Who are the leading manufacturers in the global Vaccines industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Vaccines industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Vaccines market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.